Genesis Drug Discovery & Development (GD3) logo

Candidate-Focused Chemistry

Advance Optimized Leads Toward Clinical Candidates

Integrated chemistry and ADME strategies designed to deliver compounds ready for in vivo efficacy and PK studies.

Once leads are selected, execution speed and design discipline matter. GD3 applies multi-parameter optimization to improve potency, selectivity, PK, safety, and IP strength simultaneously, preventing trade-offs that derail programs later.

Lead Optimization Capabilities

 

  • Strategic analog design aligned to your Target Product Profile

  • Parallel optimization of potency, selectivity, and ADME

  •  Early safety and developability considerations 

 

  • Seamless progression to PK and in vivo efficacy studies

  • IP-driven compound design at every cycle
HPLC

Progress from lead series to clinical candidate–ready compounds in 1–2 years.

Request a Lead Optimization Strategy Session

Schedule a consultation with our scientists to discuss your program.

During your consultation we will provide:

• Scientific recommendations for your discovery program
• Timeline and milestone projections
• Risk assessment and mitigation strategies
• Customized chemistry support plans

Contact our chemists today to learn how our medicinal chemistry expertise can accelerate your drug discovery program.